Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Island Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Painchek strives to Make American Aged Folk Comfortable Again
Health & Biotech
Biocurious: Island Pharmaceuticals’ two-pronged plan to put the mozz on dengue fever
Health & Biotech
Health Check: Which biotech boards are at risk of a ‘second strike’?
Health & Biotech
‘Breakthrough’ quarter for Island Pharmaceuticals
Health & Biotech
Health Check: It’s all in the vibe as Invion and Wellness Life shrink to share greatness
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
News
ASX Small Caps Weekly Wrap: A long run for a short slide as the ASX ends flat
Health & Biotech
Health Check: Lion City’s Orthocell approval provides a Singapore Sling-board to Asian markets
News
Closing Bell: Energy stocks cushion ASX’s mini crash; Infinity soars on Cangai copper acquisition
News
ASX Small Caps Lunch Wrap: Geopolitical turmoil still suppressing markets… buy the dip?
Health & Biotech
Island lifts 50pc on $3.5m capital raise and Phase 2a/b dengue trial progress
News
ASX Small Caps Lunch Wrap: Local bourse sleepwalks to lunch, PLS falls 5pc
Health & Biotech
Health Check: Island Pharmaceuticals raises funds to put the mozz on dengue fever outbreak
News
Top 10 at 11: A dengue fever tackler and a junior copper hunter make the news grade this morning
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Acrux hits the spot with 27pc bump after FDA approves acne gel
Health & Biotech
